• ARS Pharmaceuticals (NASDAQ:SPRY) Earns "Outperform" Rating from William Blair

    المصدر: Buzz FX / 22 فبراير 2025 22:26:17   America/New_York


    ARS Pharmaceuticals (NASDAQ:SPRY) Earns "Outperform" Rating from William Blair Written by MarketBeat February 22, 2025 Share Link copied to clipboard. ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) 's stock had its "outperform" ratin
    Read more...
شارك على،